153 related articles for article (PubMed ID: 23263912)
1. Polymorphism of TS 3'-UTR predicts survival of Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.
Gao J; He Q; Hua D; Mao Y; Li Y; Shen L
Clin Transl Oncol; 2013 Aug; 15(8):619-25. PubMed ID: 23263912
[TBL] [Abstract][Full Text] [Related]
2. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
Huang ZH; Hua D; Li LH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):911-8. PubMed ID: 18704422
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy.
Kawakami K; Graziano F; Watanabe G; Ruzzo A; Santini D; Catalano V; Bisonni R; Arduini F; Bearzi I; Cascinu S; Muretto P; Perrone G; Rabitti C; Giustini L; Tonini G; Pizzagalli F; Magnani M
Clin Cancer Res; 2005 May; 11(10):3778-83. PubMed ID: 15897576
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of capecitabine in advanced breast cancer patients.
Largillier R; Etienne-Grimaldi MC; Formento JL; Ciccolini J; Nebbia JF; Ginot A; Francoual M; Renée N; Ferrero JM; Foa C; Namer M; Lacarelle B; Milano G
Clin Cancer Res; 2006 Sep; 12(18):5496-502. PubMed ID: 17000685
[TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients.
Sharma R; Hoskins JM; Rivory LP; Zucknick M; London R; Liddle C; Clarke SJ
Clin Cancer Res; 2008 Feb; 14(3):817-25. PubMed ID: 18245544
[TBL] [Abstract][Full Text] [Related]
6. Association of thymidylate synthase polymorphisms with gastric cancer susceptibility.
Graziano F; Kawakami K; Watanabe G; Ruzzo A; Humar B; Santini D; Catalano V; Ficarelli R; Merriman T; Panunzi S; Testa E; Cascinu S; Bearzi I; Tonini G; Magnani M
Int J Cancer; 2004 Dec; 112(6):1010-4. PubMed ID: 15386366
[TBL] [Abstract][Full Text] [Related]
7. Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.
Gao J; Lu M; Yu JW; Li YY; Shen L
BMC Cancer; 2011 May; 11():177. PubMed ID: 21586171
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of TUBB3 correlate with clinical outcome in Chinese patients with advanced gastric cancer receiving first-line paclitaxel plus capecitabine.
Yu J; Gao J; Lu Z; Li Y; Shen L
Med Oncol; 2012 Dec; 29(5):3029-34. PubMed ID: 22766748
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in one-carbon metabolism pathway affects survival of gastric cancer patients: Large and comprehensive study.
Zhao T; Gu D; Xu Z; Huo X; Shen L; Wang C; Tang Y; Wu P; He J; Gong W; He ML; Chen J
Oncotarget; 2015 Apr; 6(11):9564-76. PubMed ID: 25840420
[TBL] [Abstract][Full Text] [Related]
10. Association between polymorphisms of thymidylate synthase gene 5'- and 3'-UTR and gastric cancer risk: meta-analysis.
Mo A; Zhao Y; Shi Y; Qian F; Hao Y; Chen J; Yang S; Jiang Y; Luo Z; Yu P
Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 28011897
[TBL] [Abstract][Full Text] [Related]
11. Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients.
Powrózek T; Kowalski DM; Krawczyk P; Ramlau R; Kucharczyk T; Kalinka-Warzocha E; Knetki-Wróblewska M; Winiarczyk K; Dyszkiewicz W; Krzakowski M; Milanowski J
Clin Lung Cancer; 2014 Nov; 15(6):455-65. PubMed ID: 25246386
[TBL] [Abstract][Full Text] [Related]
12. Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on the disease-free survival of breast cancer patients receiving adjuvant 5-fluorouracil/methotrexate-based therapy.
Paré L; Altés A; Ramón y Cajal T; Del Rio E; Alonso C; Sedano L; Barnadas A; Baiget M
Anticancer Drugs; 2007 Aug; 18(7):821-5. PubMed ID: 17581305
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: a case-control analysis.
Zhai X; Gao J; Hu Z; Tang J; Qin J; Wang S; Wang X; Jin G; Liu J; Chen W; Chen F; Wang X; Wei Q; Shen H
BMC Cancer; 2006 May; 6():138. PubMed ID: 16723031
[TBL] [Abstract][Full Text] [Related]
14. Correlation between expression of thymidylate synthase and clinical outcome of advanced gastric cancer treated with capecitabine alone chemotherapy.
Liu XF; Zhang H; Sun JQ; Yin C; Liu TF; Yang H; Chen LH
Tumour Biol; 2014 Dec; 35(12):12409-14. PubMed ID: 25185651
[TBL] [Abstract][Full Text] [Related]
15. Folate intake along with genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase in patients with advanced gastric cancer.
Shitara K; Muro K; Ito S; Sawaki A; Tajika M; Kawai H; Yokota T; Takahari D; Shibata T; Ura T; Ito H; Hosono S; Kawase T; Watanabe M; Tajima K; Yatabe Y; Tanaka H; Matsuo K
Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1311-9. PubMed ID: 20447923
[TBL] [Abstract][Full Text] [Related]
16. TP53 Codon 72 Polymorphism Predicts Efficacy of Paclitaxel Plus Capecitabine Chemotherapy in Advanced Gastric Cancer Patients.
Zha Y; Gan P; Liu Q; Yao Q
Arch Med Res; 2016 Jan; 47(1):13-8. PubMed ID: 26696550
[TBL] [Abstract][Full Text] [Related]
17. Influence of TS and ABCB1 gene polymorphisms on survival outcomes of 5‑FU-based chemotherapy in a Chinese population of advanced gastric cancer patients.
Chen J; Ying X; Zhang L; Xiang X; Xiong J
Wien Klin Wochenschr; 2017 Jun; 129(11-12):420-426. PubMed ID: 28074308
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in Korean patients with gastric cancer].
Lee J; Jeong CK; Hong SP; Chong SY; Oh D; Hwang SG; Ahn DH; Kim S; Han JH; Kim NK
Korean J Gastroenterol; 2005 Jul; 46(1):32-8. PubMed ID: 16030402
[TBL] [Abstract][Full Text] [Related]
20. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
